Vivos Therapeutics, Inc. (VVOS)

0.2791 0.00 (0.00%) USD  |  NASDAQ  |  Aug 25, 10:11
More

Vivos Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for VVOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 19, 2026 --
July 08, 2026 --
June 04, 2026 --
May 27, 2026 --
April 22, 2026 --
April 20, 2026 --
April 17, 2026 --
December 03, 2025 --
November 17, 2025 --
September 09, 2025 --
Date Value
August 21, 2025 --
May 20, 2025 --
April 15, 2025 --
April 01, 2025 --
November 19, 2024 --
August 20, 2024 --
August 19, 2024 --
May 20, 2024 --
April 08, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Hinge Health, Inc. Upgrade
Exlites Holdings International, Inc. --
Xcelerate, Inc. --
Haemonetics Corp. Upgrade
Pro-Dex, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade